- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02794922
Effectiveness of Vitamin B in Reducing Temporomandibular Joint Disorder Pain
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Type of study : Prospective double blinded randomized control trial Sample population : patients with temporomandibular joint disorder pain who are currently undergoing treatment in Oral & Maxillofacial surgery unit, Prince Philip Dental Hospital Study Period : 2 year (1st may2015 to 1st may 2017)
Data Collection All new cases or existing TMD patients treated in oral maxillofacial surgery department, Prince Philip Dental Hospital will be acquired and screened based on inclusion and exclusion criteria. Selected patients will be categorised based on TMD axis 1 diagnosis and divided into two groups - group 1(Vitamin B) and group 2(placebo) randomly . Allocation of patients into the group will be based on computer generated by random block sequence.
Complete social demographic background of the patient will recorded according to the following format age, gender, race, education, and job.
Clinical assessment will be done to check 1. Mouth opening 2. Lateral excursion (right and left) 3. Protrusion 4. Deviation of lower jaw on opening 5. Tenderness of muscle of mastication 6. Pain - based on 10cm visual analog score.
After initial assessments, patients will be started on either vitamin B complex or placebo based on their group.
- Both group of patients will be also prescribed with Tab Ibuprofen 400mg to be taken during acute Temporomandibular joint (TMJ) pain symptoms.
- These patients will be reviewed on week 0,2,4 and 6.
- All the patients will be reviewed by blinded assessor. Each patient will be given a log book to document frequency of TMJ pain attack, maximum pain score on each attack and amount of analgesics (Ibuprofen 400mg tabs) taken.
- Log book record will be checked on their review.
- Amount of analgesics recorded in log book and compliance of Vitamin B or placebo will be cross checked with remaining tablet count.
Data Evaluation/ Statistical Analyses The statistical analysis of this study will use the standard version of Statistical Package for the Social Sciences (SPSS) version 17.0 for windows. All the data will be gathered and entered in into this software.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
-
Hong Kong, China
- Prince Philip Dental Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- minimum age of 18
- temporomandibular joint disorder with pain
- chronic condition- symptoms lasting more than 3 months with at least 2 episodes of pain in last 1 month
- language competence- in Cantonese or English
- all ethnicity
Exclusion Criteria:
- ankylosis of the joint
- limited mental capacity
- pregnancy and lactating mothers
- inability to take medications (NSAIDS-Ibuprofen or Vitamin B)
- undergoing concurrent pharmacotherapy with anti inflammatory or muscle relaxant medications
- poor general health
- history of TMJ trauma or TMJ surgery
- subjects taking Vitamin B for other uses
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Interventional
Name: Neurovit Forte tab Dosage: Each tablet contains Vitamin B1 242.5mg,
Vitamin B6 250mg, Vitamin B12 1mg Frequency: One tab, once per day Duration: 6 weeks
|
Other Names:
|
Placebo Comparator: Placebo
Capsule containing 250mg corn starch
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual Analog Scale(VAS) Pain Score
Time Frame: baseline
|
assessment of pain level with VAS score at baseline (week 0)
|
baseline
|
Visual Analog Scale(VAS) Pain Score
Time Frame: week 2
|
assessment of pain level with VAS score at week2
|
week 2
|
Visual Analog Scale(VAS) Pain Score
Time Frame: week 4
|
assessment of pain level with VAS score at week4
|
week 4
|
Visual Analog Scale(VAS) Pain Score
Time Frame: week 6
|
assessment of pain level with VAS score at week6
|
week 6
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
mouth opening measurement in millimeter (mm)
Time Frame: baseline
|
assessment of mouth opening in millimeter (mm) at baseline (week0)
|
baseline
|
mouth opening measurement in millimeter (mm)
Time Frame: week 2
|
assessment of mouth opening in millimeter (mm) at week 2
|
week 2
|
mouth opening measurement in millimeter (mm)
Time Frame: week4
|
assessment of mouth opening in millimeter (mm) at week 4
|
week4
|
mouth opening measurement in millimeter (mm)
Time Frame: week 6
|
assessment of mouth opening in millimeter (mm) at week 6
|
week 6
|
number of participants with treatment related adverse events as assessed by CTCAE v4.03
Time Frame: 6 weeks
|
Subjects will be assessed for any adverse events related to intervention , by using CYCAE v4.03, at week 0, week 2, week 4 and week 6
|
6 weeks
|
tablet count measurements to check complaince
Time Frame: 6 weeks
|
remaining tablets will be counted at end of Week 6 to check compliance rate towards treatment
|
6 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Winnie Wing Shan Choi, BDS, MDS, Faculty of Dentistry, The University of Hong Kong
- Principal Investigator: Jothi R Rajaran, DDS, Faculty of Dentistry, The University of Hong Kong
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Musculoskeletal Diseases
- Muscular Diseases
- Stomatognathic Diseases
- Jaw Diseases
- Craniomandibular Disorders
- Mandibular Diseases
- Myofascial Pain Syndromes
- Disease
- Joint Diseases
- Temporomandibular Joint Disorders
- Temporomandibular Joint Dysfunction Syndrome
- Physiological Effects of Drugs
- Micronutrients
- Vitamins
- Vitamin B Complex
Other Study ID Numbers
- UW 15 - 266
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Temporomandibular Joint Disorder
-
CES UniversityCompletedTemporomandibular Disorder | Children, Only | Pain Disorder | Joint Disorder, Temporomandibular
-
Hacettepe UniversityThe Scientific and Technological Research Council of TurkeyRecruitingTemporomandibular Joint Disorders | Temporomandibular Joint Dysfunction Syndrome | Temporomandibular Disorder | Temporomandibular Joint Pain | Manual Therapy | Temporomandibular Joint Disc DisplacementTurkey
-
TC Erciyes UniversityRecruitingTemporomandibular Joint Disorders | Temporomandibular Disorder | Temporomandibular Joint Pain | Temporomandibular Joint Osteoarthritis | Temporomandibular Joint EffusionTurkey
-
University of AlcalaCompletedTemporomandibular DisorderSpain
-
University of Nove de JulhoUnknownTemporomandibular DisorderBrazil
-
Hacettepe UniversityKarabuk UniversityRecruitingTemporomandibular Joint Disorders | Temporomandibular Joint Dysfunction Syndrome | Temporomandibular DisorderTurkey
-
Logan College of ChiropracticUnknownTemporomandibular Joint Dysfunction Syndrome | Temporomandibular Joint Disorder | Temporomandibular JointUnited States
-
Wroclaw Medical UniversityEnrolling by invitationTemporomandibular Joint Disorders | Temporomandibular Disorder | Temporomandibular Joint Osteoarthritis | Temporomandibular ArthritisPoland
-
Beirut Arab UniversityRecruitingTemporomandibular DisorderLebanon
-
Riphah International UniversityRecruitingTemporomandibular DisorderPakistan
Clinical Trials on Neurovit Forte
-
Allergopharma GmbH & Co. KGCompletedAllergy | Rhinitis | ConjunctivitisGermany
-
Ain Shams UniversityCompletedHyperactivity | Impulsivity | InattentiveEgypt
-
Hams Hamed AbdelrahmanCompleted
-
University of Medicine and Dentistry of New JerseyAVVAA World Healthcare Products, Inc.TerminatedPsoriasis | Eczema
-
University of IbadanCompletedParkinson DiseaseNigeria
-
Sherief Abd-ElsalamRecruiting
-
Al-Azhar UniversityCompleted
-
Cairo UniversityUnknown
-
Bitop AGCompleted
-
Galderma R&DCompletedAcne Vulgaris | Atrophic Acne ScarsFrance, Canada